Nuclear Magnetic Resonance–Based Metabolomics and Risk of CKD

Predictive value of circulating NMR metabolic biomarkers for type 2 diabetes risk in the UK Biobank study

(2022) Fiona Bragg et al.   BMC Medicine

Circulating serum metabolites as predictors of dementia: a machine learning approach in a 21-year follow-up of the Whitehall II cohort study

(2022) Marcos D. Machado-Fragua et al.   BMC Medicine

Metabolomic profiles predict individual multidisease outcomes

(2022) Thore Buergel et al.   NATURE MEDICINE

Cardiovascular Protection With Sodium-Glucose Cotransporter-2 Inhibitors and Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease

(2021) Pantelis Sarafidis et al.   HYPERTENSION

Plasma lipidomics in early pregnancy and risk of gestational diabetes mellitus: a prospective nested case–control study in Chinese women

(2021) Yi Wang et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Association of Kidney Function With NMR-Quantified Lipids, Lipoproteins, and Metabolic Measures in Mexican Adults

(2021) Diego Aguilar-Ramirez et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

United Kingdom Biobank (UK Biobank)

(2021) Rishi Caleyachetty et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Chronic kidney disease

(2021) Kamyar Kalantar-Zadeh et al.   LANCET

Circulating Metabolites and the Development of Type 2 Diabetes in Chinese Adults

(2021) Fiona Bragg et al.   DIABETES CARE

Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

(2020) Boris Bikbov et al.   LANCET

Plasma Metabolomics Identifies Markers of Impaired Renal Function: A Meta-analysis of 3089 Persons with Type 2 Diabetes

(2020) Nete Tofte et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke

(2018) Michael V. Holmes et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016

(2018) Yan Xie et al.   KIDNEY INTERNATIONAL

Circulating metabolic biomarkers of renal function in diabetic and non-diabetic populations

(2018) Clara Barrios et al.   Scientific Reports

Nuclear magnetic resonance-based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation: results from PROSPER and FINRISK 1997

(2017) Christian Delles et al.   EUROPEAN JOURNAL OF HEART FAILURE

Metabolomics for clinical use and research in chronic kidney disease

(2017) Berthold Hocher et al.   Nature Reviews Nephrology

High-density lipoprotein subclass measurements improve mortality risk prediction, discrimination and reclassification in a cardiac catheterization cohort

(2016) Robert W. McGarrah et al.   ATHEROSCLEROSIS

Metabolic profiling of fatty liver in young and middle-aged adults: Cross-sectional and prospective analyses of the Young Finns Study

(2016) Jari E. Kaikkonen et al.   HEPATOLOGY

Metabolite Profiling and Cardiovascular Event Risk: A Prospective Study of 3 Population-Based Cohorts

(2015) P. Wurtz et al.   CIRCULATION

Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease

(2015) Merlin C. Thomas et al.   Nature Reviews Nephrology

UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age

(2015) Cathie Sudlow et al.   PLOS MEDICINE

Serum Metabolomic Profiling and Incident CKD among African Americans

(2014) B. Yu et al.   Clinical Journal of the American Society of Nephrology

Biomarker Profiling by Nuclear Magnetic Resonance Spectroscopy for the Prediction of All-Cause Mortality: An Observational Study of 17,345 Persons

(2014) Krista Fischer et al.   PLOS MEDICINE

Triglyceride-cholesterol imbalance across lipoprotein subclasses predicts diabetic kidney disease and mortality in type 1 diabetes: the FinnDiane Study

(2013) V.-P. Mäkinen et al.   JOURNAL OF INTERNAL MEDICINE

A Combined Epidemiologic and Metabolomic Approach Improves CKD Prediction

(2013) E. P. Rhee et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Metabolic Diversity of Progressive Kidney Disease in 325 Patients with Type 1 Diabetes (the FinnDiane Study)

(2011) Ville-Petteri Mäkinen et al.   JOURNAL OF PROTEOME RESEARCH

Sphingomyelin is associated with kidney disease in type 1 diabetes (The FinnDiane Study)

(2011) Ville-Petteri Mäkinen et al.   Metabolomics

Discovering the false discovery rate

(2010) Yoav Benjamini   JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

(2010) Michael J. Pencina et al.   STATISTICS IN MEDICINE